New hope for Hard-to-Treat thyroid cancer: lenvatinib shows promise
Disease control
Completed
This study looked at the safety of lenvatinib in 50 adults with advanced thyroid cancer that has spread and no longer responds to standard radioiodine therapy. Researchers tracked side effects and how often doses needed to be reduced. The goal was to see if lenvatinib can help co…
Phase: PHASE4 • Sponsor: Eisai Pharmaceuticals India Pvt. Ltd • Aim: Disease control
Last updated May 14, 2026 12:06 UTC